Tag: Chemotherapy
Antigen Level Signals Response to Chemo for Pancreatic Cancer
Overall survival, time to progression longer with early drop of >10 percent in carbohydrate antigen 19-9
Diastolic Dysfunction Common After Anthracycline Chemo
BMI and age independently linked to diastolic dysfunction after anthracycline chemotherapy
New Rx Strategy May Up Survival in Advanced Prostate Cancer
Adding chemotherapy to hormone therapy added 14 months to patients' lives in study
Intraperitoneal Chemotherapy Ups Ovarian Cancer Outcomes
However, only 41 percent of suitable candidates actually receive the therapy
Chemotherapy Use Doesn’t Improve QOL Near Death
No improvement in quality of life, even for patients with good baseline performance status
Worse Survival With Chemo Dose Reduction in Ovarian Cancer
Lower average relative dose intensity linked to worse overall and ovarian cancer-specific survival
Vessel Boost Tied to Improved Surgical Resection Rate
Findings in patients with borderline resectable, locally-advanced pancreatic cancer
ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
Benefits for Surgery Before Chemo in Advanced Ovarian CA
Appears to raise quality of life without shortening survival
ASCO: Docetaxel With Hormone Tx May Improve Outcomes
Combination with hormone therapy can extend life by almost a year for prostate cancer patients
